What Researchers Did
Researchers investigated the criteria chronically ill patients use to decide whether to continue hyperbaric oxygen therapy for multiple sclerosis by surveying 48 trial participants.
What They Found
Physical factors, including stabilization or improvement, were the most common reasons cited for continuing treatment among the 48 participants. Conversely, lack of effectiveness was frequently given as a reason to stop therapy six months post-trial, alongside social and practical considerations. Patients' personal experience and knowledge of hyperbaric oxygen effects on others were more influential than anticipated formal trial results.
What This Means for Canadian Patients
Canadian patients with chronic conditions like multiple sclerosis may prioritize personal experience and perceived physical benefits when deciding whether to continue long-term therapies. Healthcare providers should consider these patient-centric factors, alongside practical and social support needs, when discussing treatment adherence.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The study's findings are based on self-reported reasons from participants in a specific hyperbaric oxygen therapy trial for multiple sclerosis, which may limit generalizability.